Barcelona-based Gate2Brain secures β¬7 million to advance brain tumour candidate
Barcelona-based Gate2Brain secures β¬7 million to advance brain tumour therapy. The Spanish BioTech firm's largest investment to date partners them with Shilpa Biocare Pvt Ltd.
EU-Startups
Read more 16 jun 2026
